Privia Health Group, Inc.

Annual Trend FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026
Cash flows from operating activities:
Adjustments to reconcile net income to net cash provided by operating activities:
Net Income From Continuing Operations ($12.1m) $21.0m $17.0m $29.7m
Net Income (Loss) Attributable to Parent $7.9m $31.2m ($188.2m) ($8.6m) $23.1m $14.4m $22.9m
Adjustments to reconcile profit (loss) $48.4m $16.9m $3.0m $26.6m $25.9m $38.2m $36.8m
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest $30.9m ($190.6m) ($12.1m) $21.0m $17.0m $29.7m
Net Income (Loss) Attributable to Noncontrolling Interest ($340k) ($2.4m) ($3.5m) ($2.1m) $2.7m $6.8m
Depreciation, Depletion and Amortization $784k $1.8m $2.5m $4.6m $6.5m $7.3m $9.9m $22.1m
Depreciation $784k $1.2m $1.2m $1.2m $1.2m $1.1m $739k $22.1m
Amortization of Debt Issuance Costs $100k $200k $700k $0
Amortization of Intangible Assets $642k $1.3m $3.4m $5.4m $6.2m $9.2m
Amortization of intangibles $643k $642k $1.3m $3.4m $5.4m $6.2m $9.2m
Amortization Cash Flow $3.4m $5.4m $6.2m $9.2m
Depreciation Amortization Depletion $4.6m $6.5m $7.3m $9.9m
Deferred Income Tax Expense (Benefit) ($7.8m) ($28.4m) ($7.0m) $7.5m $8.8m $10.9m
Deferred income taxes $716k ($7.8m) ($28.4m) ($7.0m) $7.5m $8.8m $10.9m
Deferred taxes ($3.2m) ($3.8m) ($3.0m) ($6.8m) ($256k) $1.5m ($1.5m)
Deferred Income Tax ($7.0m) $7.5m $8.8m $10.9m
Deferred Tax ($7.0m) $7.5m $8.8m $10.9m
Share-based Payment Arrangement, Noncash Expense $484k $253.5m $67.4m $37.1m $56.7m $71.1m
Share-based Payment Arrangement, Expense $484k $253.5m $67.4m $37.1m $56.7m $71.1m
Goodwill, Impairment Loss $0 $0 $0
Impairment of Intangible Assets (Excluding Goodwill) $0 $0 $0
Share-based compensation $2.9m $5.6m $3.3m $6.7m $4.9m $4.0m $5.5m
Impairment of goodwill and intangibles $0 $5.1m $41.1m
Share-based compensation granted on business acquisition $0 ($1.3m) $0
Income Tax Expense (Benefit) ($7.4m) ($27.9m) ($6.5m) $8.0m $10.8m $14.2m
Operating lease liabilities $0 $0 $13.9m ($2.4m) ($3.2m) ($2.7m) ($2.5m)
Loss on disposal of property and equipment, intangible and lease modification $0 $218k $0 $3.7m $1.5m $150k $515k
Changes in operating assets and liabilities:
Changes in non-cash working capital items $5.7m ($86k) ($1.1m) $2.3m ($10.2m) $10.2m ($11.0m)
Additional Financial Items
Increase (Decrease) in Accounts Receivable $21.8m $14.6m $72.2m $96.9m $19.8m $36.7m
Increase (Decrease) in Accounts Payable $5.0m $19.9m $14.8m
Proceeds from Stock Options Exercised $108k $3.8m $13.4m $8.7m $2.7m $8.0m
General and Administrative Expense $44.0m $255.9m $129.6m $109.6m $126.2m $138.2m
Goodwill $118.7m $127.9m $126.9m $138.7m $141.6m $209.8m
Nonoperating Income (Expense) $10.9m $9.7m
Operating Expenses $791.7m $1.2b $1.4b $1.6b $1.7b $2.1b
Revenue from Contract with Customer, Including Assessed Tax $817.1m $966.2m $1.4b $1.7b $1.7b $2.1b
Stock-based compensation $207k $484k $253.5m $67.4m $37.1m $56.7m $71.1m
Accounts receivable, net ($6.2m) ($21.8m) ($14.6m) ($72.2m) ($96.9m) ($19.8m) ($36.7m)
Prepaid expenses and other current assets ($151k) ($962k) ($1.3m) ($5.7m) ($6.2m) ($9.0m) ($1.6m)
Other non-current assets and right-of-use assets ($2.4m) $1.2m ($9.7m) $1.4m ($2.4m) ($1.7m) ($326k)
Accounts payable and accrued expenses $2.1m $9.7m $1.3m $6.9m $5.0m $19.9m $14.8m
Provider liability $24.5m $33.9m $67.7m $113.4m $32.9m $65.6m
Other long-term liabilities $4.8m $672k ($5.5m) ($2.0m) ($1.0m) ($160k) $2.4m
Acquisitions, net of cash acquired $0 $0 ($32.2m) $0 ($42.9m) ($7.0m) ($180.4m)
Other $0 ($138k) ($104k) ($113k) ($5.0m) ($1.2m)
Repurchase of non-controlling interest $0 $0 ($5.7m) $0 $0
Proceeds from non-controlling interest $0 $0 $125k $659k $1.7m $0
Distribution to non-controlling interest $0 $0 ($1.3m)
Proceeds from exercised stock options $0 $108k $3.8m $13.4m $8.7m $2.7m $8.0m
Leases liabilities obtained in exchange for right-of-use assets $0 $0 $6.4m
Net (loss) earnings ($39.7m) ($17.3m) ($15.5m) ($30.1m) ($16.7m) $1.3m ($38.8m)
Change in fair value of contingent consideration $0 $9.2m ($3.8m) ($5.6m) ($2.1m)
Net financial expenses $231k $242k $4.6m $9.3m $11.9m $8.9m $9.5m
Unrealized foreign exchange loss (gain) $273k $1.3m $299k ($318k) $153k ($966k) $1.0m
Cash settlement of RSUs, DSUs and PSUs ($371k) ($264k) $0
Additions to intangibles ($49k) ($166k) ($1.4m) ($849k) ($41k) ($239k) ($316k)
Advances on the Credit Facility, net of related transaction costs $64.1m $53.5m $156.8m $98.7m $148.3m $102.7m $61.4m
Repayment of the Credit Facility ($54.4m) ($49.9m) ($146.5m) ($97.5m) ($159.1m) ($110.3m) ($50.8m)
Repayment of secured loans ($8.5m) $0
Repayment of balances of purchase price payable ($4.3m) ($7.7m)
Repayment of lease liabilities, including lease termination costs ($1.8m) ($1.4m) ($2.7m) ($3.7m) ($5.8m) ($4.6m) ($3.8m)
Exercise of stock options $165k $300k $299k $346k $6k $0 $100k
Shares purchased for settlement of RSUs $0 $0 ($29k) $0 ($148k) ($205k)
Shares purchased for cancellation $0 ($1.2m) ($1.0m) ($953k) ($402k) ($5.2m)
Financial expenses paid $3.5m $8.1m ($11.0m) ($8.0m) ($8.1m)
Cash, beginning of year ($4.0m) ($1.9m) $10.8m $4.9m ($13.7m) $7.1m ($3.1m)
Cash, end of year $12.8m $8.8m $17.7m $17.7m $8.9m $16.0m $12.8m
Settlement of RSUs $0 ($371k)
Forgiveness of PPP loans $0 ($1.9m) ($5.9m) $0
Loss on disposal of intangibles $28.0m $0 $262k $0
Right-of-use assets $222k $0 ($132k) $0
Proceeds from issuing shares $24.7m $0
Lease incentives $0 $917k $0
Interest accretion on balances of purchase payable $318k $835k $823k
Gain on sale of subsidiary ($681k) $0
Short-term deposits $1.3m $0
Line of credit and demand loan drawn (repaid) ($3.2m) $0
Beginning Cash Position $320.6m $348.0m $389.5m $491.1m
Cash Flow From Continuing Financing Activities ($19.7m) $3.7m $4.3m $6.7m
Cash Flow From Continuing Investing Activities ($104k) ($43.0m) ($12.0m) ($181.6m)
Change In Other Current Assets $1.4m ($2.4m) ($1.7m) ($326k)
Change In Other Current Liabilities $63.3m $109.1m $30.1m $65.6m
Change In Payables And Accrued Expense $6.9m $5.0m $19.9m $14.8m
Change In Prepaid Assets ($5.7m) ($6.2m) ($9.0m) ($1.6m)
Change In Receivables ($72.2m) ($96.9m) ($19.8m) ($36.7m)
Change In Working Capital ($6.4m) $8.7m $19.5m $41.8m
Changes In Account Receivables ($72.2m) ($96.9m) ($19.8m) ($36.7m)
Changes In Cash $27.4m $41.5m $101.6m ($11.5m)
End Cash Position $348.0m $389.5m $491.1m $479.7m
Financing Cash Flow ($19.7m) $3.7m $4.3m $6.7m
Free Cash Flow $47.2m $80.8m $109.3m $163.4m
Investing Cash Flow ($104k) ($43.0m) ($12.0m) ($181.6m)
Issuance Of Capital Stock $223.7m $0 $0
Net Business Purchase And Sale $0 ($42.9m) ($7.0m) ($180.4m)
Net PPE Purchase And Sale ($547k) ($104k) ($113k)
Other Non Cash Items $157k $687k
Proceeds From Stock Option Exercised $13.4m $8.7m $2.7m $8.0m
Purchase Of Business $0 ($42.9m) ($7.0m) ($180.4m)
Purchase Of PPE ($547k) ($104k) ($113k)
Net Cash Provided by (Used in) Operating Activities $24.4m $38.9m $55.1m $47.2m $80.8m $109.3m $163.4m $25.8m
Cash flows from investing activities:
Payments to Acquire Property, Plant, and Equipment $380k $547k $104k $113k ($746k) ($1.2m) ($1.4m)
Payments to Acquire Businesses, Net of Cash Acquired $0 $32.2m $0 $42.9m $7.0m $180.4m
Business acquisitions, net of cash acquired ($15.2m) $0 ($15.7m) ($14.4m) $0 ($6.4m) ($10.9m)
Business divestiture, cash disposed $0 ($951k)
Payments for (Proceeds from) Other Investing Activities $5.0m $1.2m
Net Other Investing Changes ($104k) ($113k) ($5.0m) ($1.2m)
Net Cash Provided by (Used in) Investing Activities ($5.7m) ($380k) ($32.8m) ($104k) ($43.0m) ($12.0m) ($181.6m) ($13.6m)
Cash flows from financing activities:
Issuance Of Debt $0 $0
Net Issuance Payments Of Debt ($875k) ($33.2m) $0 $0
Net Long Term Debt Issuance ($875k) ($33.2m) $0 $0
Net Short Term Debt Issuance $0 $0
Short Term Debt Issuance $0 $0
Realized foreign exchange (gain) loss on repayment of long-term debt $81k ($879k) ($250k) $861k ($26k) $580k ($604k)
Repayment of other long-term debt ($450k) ($350k)
Long Term Debt Payments ($875k) ($33.2m) $0 $0
Repayment Of Debt ($875k) ($33.2m) $0 $0
Short Term Debt Payments $0 $0
Common Stock Issuance $223.7m $0 $0
Net Common Stock Issuance $223.7m $0 $0
Proceeds from Noncontrolling Interests $125k $659k $1.7m $0
Net Other Financing Charges $125k ($5.0m) $1.7m ($1.3m)
Net cash (used in) from financing activities $4.9m $3.4m $27.9m ($11.3m)
Net Cash Provided by (Used in) Financing Activities ($10.9m) ($767k) $213.7m ($19.7m) $3.7m $4.3m $6.7m ($14.7m)
Effect of exchange rate changes on cash $579k ($308k) ($77k) $1.1m ($29k) $636k ($596k)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $37.7m $235.9m $27.4m $41.5m $101.6m ($11.5m)
Net (decrease) increase in cash and cash equivalents $7.8m $37.7m $235.9m $27.4m $41.5m $101.6m ($11.5m)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $84.6m $320.6m $348.0m $389.5m $491.1m $479.7m
Cash and cash equivalents at beginning of period $46.9m $84.6m $320.6m $348.0m $389.5m $491.1m $479.7m
Restricted cash $47k ($1.0m) ($21k) $3.3m $0
Supplemental disclosure of cash flow information:
Change In Cash Supplemental As Reported $27.4m $41.5m $101.6m ($11.5m)
Interest Paid, Excluding Capitalized Interest, Operating Activities $9.2m $1.9m $888k $713k $40k $285k $251k
Income Taxes Paid, Net $316k $381k $504k $307k $1.0m $3.8m $6.6m ($72k)

Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.